Knowledge Center

Article / Aug 01, 2014

Pharmaceutical Manufacturing and Supply-Chain Trends to 2020

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology Europe, August 2014

A breach in the pharmaceutical supply chain is only the tip of the iceberg.
Innovators (Big Pharma and biotech companies) are today a minority player supplying only about 20% of the world鈥檚 medicines. At present, the vast majority of medicines are generic鈥攖he fruits of the best science of the 20th century can now be enjoyed for a few cents a pill.

Related links

Also in the Knowledge Center

Related Content

Inspections History

四色AV sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Membrane Technology

四色AV has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more

Analytical Characterization

四色AV advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.

Page
Read more